Delta Sleep-Inducing Peptide (sleep/anti-stress)

DSIP

Research use only

Written by pep4U Editorial Team · Last reviewed October 12, 2026

A naturally occurring nonapeptide first identified from delta-wave sleep experiments; studied for sleep and stress resilience.

Go deeper. We have a full, in-depth research deep dive on this compound. Read it →

Class / type	Delta Sleep-Inducing Peptide (sleep/anti-stress)
Category	Cognitive & Nootropic
Status (Jul 2026)	Research use only

Key points

Delta Sleep-Inducing Peptide - a natural peptide studied for sleep and stress.
May promote deep (slow-wave) sleep, but the mechanism is poorly mapped.
Clinical results are mixed; not FDA-approved.
Reported to give deeper sleep without a 'hangover' or dependence.

Overview

DSIP is a naturally occurring nonapeptide first identified in the 1970s from delta-wave (deep) sleep experiments. It's studied for sleep quality and stress resilience and is popular among people seeking a non-sedative sleep aid.

It's not FDA-approved and is sold as a research chemical; notably, the science behind it remains surprisingly unsettled.

How it works

DSIP appears to promote slow-wave sleep and interact with stress-response and circadian/neuroendocrine systems, but no single receptor or validated pathway has been established - its mechanism is genuinely not well understood.

What the research shows

Some early insomnia studies reported modest improvements in sleep efficiency and latency, and it's generally described as well tolerated in research. But results across studies are mixed and inconsistent, and rigorous modern trials are lacking.

Benefits

Users report subjectively deeper, more restorative sleep and a calmer stress response, without the grogginess or dependence associated with sedative sleep drugs.

Reported to be gentle and well tolerated.

Risks & side effects

The evidence is inconsistent and the mechanism poorly mapped, so efficacy is uncertain. Long-term human safety data are limited.

Reported side effects are mild (headache, dizziness, GI), and gray-market purity is a concern.

Practical considerations

Research-use-only in the US. It was reviewed by the FDA's Pharmacy Compounding Advisory Committee in July 2026 (as 'Emideltide') but, unlike the other peptides in that review, was not recommended for the 503A compounding list. Typically used before bed in community protocols, and no dose is sanctioned.

What people like most (reported community sentiment - not endorsement)

Subjectively deeper, more restorative sleep and a calmer stress response without a 'hangover' or dependence.

Frequently asked questions

What is DSIP for?

Primarily sleep quality and stress resilience; it's studied for insomnia and deeper slow-wave sleep.

Does DSIP actually work?

Results are mixed - some early studies showed modest sleep benefits, but the evidence is inconsistent and the mechanism isn't well understood.

Is it FDA-approved?

No. It is research-use-only in the US. An FDA advisory panel reviewed it in July 2026 but, unlike the others in that review, did not recommend it for compounding.

Will it make me groggy?

Users report deeper sleep without the 'hangover' or dependence of sedative sleep drugs, but individual results vary.

Is it safe?

Reported effects are mild, but long-term human safety data are limited.

Legal / regulatory status

NOT FDA-approved; research-use-only. Reviewed by the FDA's PCAC on Jul 24, 2026 (as 'Emideltide') and, unlike the other six peptides in that review, it was NOT recommended for the 503A compounding list (6 yes, 7 no, 1 abstention).

Dig into the research

Recommended supplies

See all supplies →

As an Amazon Associate we earn from qualifying purchases.

← Back to Cognitive & Nootropic